UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Oak Hill Wealth Advisors LLC

Oak Hill Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,727 shares of the healthcare conglomerate’s stock after buying an additional 105 shares during the quarter. Oak Hill Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,428,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $6,375,744,000. GAMMA Investing LLC lifted its stake in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $1,914,740,000. Amundi lifted its stake in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after buying an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after buying an additional 2,301,010 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.1%

Shares of UNH stock opened at $302.19 on Thursday. The business’s fifty day moving average price is $342.22 and its 200 day moving average price is $458.07. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm has a market capitalization of $274.13 billion, a PE ratio of 12.65, a P/E/G ratio of 1.45 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the company posted $6.91 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.93%. UnitedHealth Group’s dividend payout ratio is 37.02%.

Analyst Ratings Changes

A number of brokerages have weighed in on UNH. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Morgan Stanley reduced their price objective on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a research note on Friday, June 20th. Oppenheimer cut their price target on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. Finally, Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price target for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $415.57.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer now owns 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.